ZFP30

gene
On this page

Also known as ZNF745KIAA0961

Summary

ZFP30 (ZFP30 zinc finger protein, HGNC:29555) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 30 homolog (Q9Y2G7). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 22835 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 73 total — 1 likely-pathogenic
  • MANE Select transcript: NM_001320669

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29555
Approved symbolZFP30
NameZFP30 zinc finger protein
Location19q13.12
Locus typegene with protein product
StatusApproved
AliasesZNF745, KIAA0961
Ensembl geneENSG00000120784
Ensembl biotypeprotein_coding
OMIM617317
Entrez22835

Gene structure

Transcript identifiers

Ensembl transcripts: 22 — 18 protein_coding, 3 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000351218, ENST00000477900, ENST00000514101, ENST00000586732, ENST00000587199, ENST00000587809, ENST00000588979, ENST00000589018, ENST00000589676, ENST00000589789, ENST00000591444, ENST00000684514, ENST00000858104, ENST00000858105, ENST00000858106, ENST00000858107, ENST00000858108, ENST00000858109, ENST00000937928, ENST00000937929, ENST00000937930, ENST00000943956

RefSeq mRNA: 7 — MANE Select: NM_001320669 NM_001320666, NM_001320667, NM_001320668, NM_001320669, NM_001320670, NM_001320671, NM_014898

CCDS: CCDS33005

Canonical transcript exons

ENST00000684514 — 6 exons

ExonStartEnd
ENSE000013988163765471237654879
ENSE000025140633764326537643363
ENSE000025294043764461037644736
ENSE000035565463764781437647899
ENSE000039177863765542037655465
ENSE000039211803763100637636305

Expression profiles

Bgee: expression breadth ubiquitous, 218 present calls, max score 89.60.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.7732 / max 108.5483, expressed in 1584 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1807234.96161551
1807290.4141232
1807310.3882168
1807220.00932

Top tissues by expression

264 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534389.60gold quality
ganglionic eminenceUBERON:000402385.59gold quality
ventricular zoneUBERON:000305384.22gold quality
calcaneal tendonUBERON:000370183.22gold quality
colonic epitheliumUBERON:000039783.17gold quality
oocyteCL:000002382.98gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.25gold quality
adrenal tissueUBERON:001830380.61gold quality
secondary oocyteCL:000065579.97gold quality
pigmented layer of retinaUBERON:000178279.86gold quality
embryoUBERON:000092279.68gold quality
cerebellar cortexUBERON:000212979.05gold quality
cerebellar hemisphereUBERON:000224579.00gold quality
stromal cell of endometriumCL:000225578.81gold quality
right hemisphere of cerebellumUBERON:001489078.63gold quality
left testisUBERON:000453378.20gold quality
right testisUBERON:000453478.11gold quality
cerebellumUBERON:000203778.10gold quality
tendonUBERON:000004377.84gold quality
seminal vesicleUBERON:000099877.78gold quality
testisUBERON:000047377.36gold quality
endometriumUBERON:000129577.29gold quality
islet of LangerhansUBERON:000000676.33gold quality
prefrontal cortexUBERON:000045176.11gold quality
corpus callosumUBERON:000233675.44gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099175.42gold quality
left ovaryUBERON:000211974.17gold quality
sural nerveUBERON:001548874.07gold quality
ovaryUBERON:000099274.04gold quality
body of uterusUBERON:000985374.01gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-7303no359.75
E-MTAB-7249no191.02
E-ANND-3no5.45

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): STAT1

miRNA regulators (miRDB)

102 targeting ZFP30, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-188-3P100.0068.761240
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-4481100.0066.421669
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-656-3P100.0072.152788
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-150-5P99.9966.691976
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-548P99.9872.253784
HSA-MIR-3692-3P99.9870.272139
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-569699.9872.364487
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-590-3P99.9674.346478
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-627-3P99.9071.423316
HSA-MIR-153-5P99.8973.866317
HSA-MIR-548D-3P99.8770.674362
HSA-MIR-182-5P99.8774.032589
HSA-MIR-548BB-3P99.8670.584354
HSA-MIR-221-3P99.8671.561329
HSA-MIR-222-3P99.8671.351337

Literature-anchored findings (GeneRIF, showing 1)

  • Using murine and human in vitro and in vivo models, study demonstrated that ZFP30 promotes adipogenesis by directly targeting and activating a retrotransposon-derived Pparg2 enhancer. Through mechanistic studies, study further show that ZFP30 recruits the co-regulator KAP1, which acts as a ZFP30 co-activator in this adipogenic context. (PMID:31000713)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusZfp30ENSMUSG00000047473
rattus_norvegicusZfp84ENSRNOG00000055519

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)

Protein

Protein identifiers

Zinc finger protein 30 homologQ9Y2G7 (reviewed: Q9Y2G7)

Alternative names: Zinc finger protein 745

All UniProt accessions (5): D3Y2A0, Q9Y2G7, K7EK76, K7EMM3, K7EPH5

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (7): NP_001307595, NP_001307596, NP_001307597, NP_001307598, NP_001307599, NP_001307600, NP_055713 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (18 total): zinc finger region 13, cross-link 2, chain 1, domain 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9Y2G7-F172.410.13

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3): 75, 110, 141

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 107 (showing top): GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, EPPERT_LSC_R, WONG_ADULT_TISSUE_STEM_MODULE, E2F3_UP.V1_UP, RB_DN.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX5_TARGET_GENES, DYRK1A_TARGET_GENES, HMG20B_TARGET_GENES, HMGA1_TARGET_GENES, KLF7_TARGET_GENES, OVOL3_TARGET_GENES

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
regulation of transcription by RNA polymerase II1
transition metal ion binding1
nucleic acid binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

516 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZFP30SPDYE11P0DTA3507
ZFP30C12orf42Q96LP6357
ZFP30ZDHHC11BP0C7U3348
ZFP30CNTNAP3BQ96NU0322
ZFP30TCP11L2Q8N4U5319
ZFP30DIPK1CQ0P6D2318
ZFP30SPATA32Q96LK8310
ZFP30KCTD19Q17RG1302
ZFP30TMC7Q7Z402286
ZFP30LRRC14Q15048282
ZFP30JKAMPQ9P055271
ZFP30ZNF512Q96ME7270
ZFP30SP140LQ9H930270
ZFP30PLSCR2Q9NRY7269
ZFP30JADE1Q6IE81258

IntAct

9 interactions, top by confidence:

ABTypeScore
AURKBSEC16Apsi-mi:“MI:2364”(proximity)0.570
TRIM28ZNF316psi-mi:“MI:0914”(association)0.530
ZNF467ZNF320psi-mi:“MI:0914”(association)0.350
CBX6ZNF316psi-mi:“MI:0914”(association)0.350
LYARMPHOSPH10psi-mi:“MI:0914”(association)0.350
CDK7TAF4psi-mi:“MI:2364”(proximity)0.270
GOLGA2MYO1Cpsi-mi:“MI:2364”(proximity)0.270
MYOD1BCL9psi-mi:“MI:2364”(proximity)0.270

BioGRID (14): ZFP30 (Proximity Label-MS), ZFP30 (Proximity Label-MS), ZFP30 (Proximity Label-MS), ZFP30 (Affinity Capture-RNA), ZFP30 (Proximity Label-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Proximity Label-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Affinity Capture-MS), ZFP30 (Proximity Label-MS), ZFP30 (Affinity Capture-RNA)

ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21

Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

73 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic1
Uncertain significance61
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
224819NM_001320669.3(ZFP30):c.730T>C (p.Cys244Arg)Likely pathogenic

SpliceAI

2198 predictions. Top by Δscore:

VariantEffectΔscore
19:37647812:A:ACdonor_gain1.0000
19:37647813:C:CCdonor_gain1.0000
19:37647813:CA:Cdonor_gain1.0000
19:37647813:CACGA:Cdonor_gain1.0000
19:37647895:CAGAG:Cacceptor_gain1.0000
19:37647896:AGAGC:Aacceptor_loss1.0000
19:37647897:GAG:Gacceptor_gain1.0000
19:37647897:GAGC:Gacceptor_loss1.0000
19:37647899:GC:Gacceptor_loss1.0000
19:37647900:C:CCacceptor_gain1.0000
19:37647901:T:Cacceptor_loss1.0000
19:37655109:C:Adonor_gain1.0000
19:37636305:TC:Tacceptor_loss0.9900
19:37636306:C:Gacceptor_loss0.9900
19:37636307:T:Gacceptor_loss0.9900
19:37644642:A:ACdonor_gain0.9900
19:37647808:ACTT:Adonor_loss0.9900
19:37647810:T:TAdonor_loss0.9900
19:37647811:TACAC:Tdonor_loss0.9900
19:37647812:ACAC:Adonor_loss0.9900
19:37647813:CACG:Cdonor_gain0.9900
19:37647896:AGAG:Aacceptor_gain0.9900
19:37647913:A:Cacceptor_gain0.9900
19:37654710:A:ACdonor_gain0.9900
19:37654711:C:CCdonor_gain0.9900
19:37655108:T:TAdonor_gain0.9900
19:37655230:C:CTdonor_gain0.9900
19:37655231:T:TTdonor_gain0.9900
19:37686519:CAGA:Cacceptor_gain0.9900
19:37686523:C:CCacceptor_gain0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000010153 (19:37644127 C>A,T), RS1000047376 (19:37638619 G>T), RS1000052870 (19:37656454 T>C,G), RS1000081452 (19:37645433 T>C), RS1000085011 (19:37656186 G>A), RS1000312596 (19:37633143 C>A,T), RS1000323916 (19:37632987 A>G), RS1000545072 (19:37639661 T>G), RS1000689267 (19:37645796 A>T), RS1000743002 (19:37646084 C>T), RS1001054056 (19:37657727 G>A), RS1001152048 (19:37655306 A>C), RS1001314146 (19:37634835 T>C,G), RS1001328966 (19:37634384 A>G), RS1001349231 (19:37649682 G>A,C)

Disease associations

OMIM: gene MIM:617317 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST010002_55Refractive error7.000000e-09

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression4
trichostatin Adecreases expression, affects cotreatment2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
TAK-243increases sumoylation1
triphenyl phosphateaffects expression1
manganese chlorideincreases expression, increases abundance1
vanadyl sulfatedecreases expression1
di-n-butylphosphoric acidaffects expression1
2-palmitoylglycerolincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
dorsomorphindecreases expression, affects cotreatment1
jinfukangdecreases expression1
Temozolomideincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Benzo(a)pyrenedecreases methylation1
Cisplatindecreases expression1
Formaldehydedecreases expression1
Gallic Aciddecreases expression1
Manganeseincreases expression, increases abundance1
S-Nitrosoglutathioneincreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.